Robert Karofsky - UBS Group President
| UBSN Stock | MXN 689.00 31.00 4.31% |
President
Mr. Robert Karofsky is CoPresident Investment Bank, Member of the Executive Board of the Company. He is coPresident Investment Bank of UBS Group AG and UBS AG and became a member of the GEB in October 2018. He joined UBS in 2014 as Global Head Equities and was President UBS Securities LLC since 2015. From 2011 to 2014, he was Global Head of Equity Trading at AllianceBernstein. He began his career at Morgan Stanley in 1994 and joined Deutsche Bank as Head of North American Equities in 2005, later becoming coHead of Global Equities from 2008 to 2010 since 2018.
| Age | 56 |
| Tenure | 7 years |
| Professional Marks | MBA |
| Phone | 41 44 234 11 11 |
| Web | https://www.ubs.com |
UBS Group Management Efficiency
UBS Group's management efficiency ratios could be used to measure how well UBS Group manages its routine affairs as well as how well it operates its assets and liabilities.UBS Group AG has accumulated 188.26 B in total debt. Debt can assist UBS Group until it has trouble settling it off, either with new capital or with free cash flow. So, UBS Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like UBS Group AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for UBS to invest in growth at high rates of return. When we think about UBS Group's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 12 records | PRESIDENT Age | ||
| Andrew Nocella | United Airlines Holdings | 53 | |
| David Wichmann | UnitedHealth Group Incorporated | 56 | |
| Robert Telesmanic | Cognizant Technology Solutions | 56 | |
| Andrew Iaboni | McEwen Mining | 41 | |
| Srinivasan Veeraraghavachary | Cognizant Technology Solutions | 63 | |
| Marianne Short | UnitedHealth Group Incorporated | 68 | |
| Linda Jojo | United Airlines Holdings | 58 | |
| John Rex | UnitedHealth Group Incorporated | 61 | |
| Thomas Roos | UnitedHealth Group Incorporated | 50 | |
| William Deckelman | DXC Technology | 65 | |
| Gerald Laderman | United Airlines Holdings | 65 | |
| Brett Hart | United Airlines Holdings | 53 | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0069 |
UBS Group AG Leadership Team
Elected by the shareholders, the UBS Group's board of directors comprises two types of representatives: UBS Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UBS. The board's role is to monitor UBS Group's management team and ensure that shareholders' interests are well served. UBS Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UBS Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Suni Harford, Pres Board | ||
| Kian Koh, Pres Board | ||
| Michael Dargan, Chief Board | ||
| Sabine KellerBusse, Group Head Human Resources | ||
| Christian Bluhm, Group Chief Risk Officer | ||
| Markus Ronner, Group Chief Compliance and Governance Officer, Member of the Executive Board | ||
| Sarah Youngwood, Group Board | ||
| Robert Karofsky, Co-President Investment Bank, Member of the Executive Board | ||
| Iqbal CPA, Pres Management | ||
| Ralph Hamers, Group Board |
UBS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UBS Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0069 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 1.08 T | |||
| Shares Outstanding | 3.11 B | |||
| Shares Owned By Insiders | 0.06 % | |||
| Shares Owned By Institutions | 56.50 % | |||
| Price To Earning | 200.37 X | |||
| Price To Book | 1.00 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for UBS Stock Analysis
When running UBS Group's price analysis, check to measure UBS Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UBS Group is operating at the current time. Most of UBS Group's value examination focuses on studying past and present price action to predict the probability of UBS Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UBS Group's price. Additionally, you may evaluate how the addition of UBS Group to your portfolios can decrease your overall portfolio volatility.